Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Rachel Vatnsdal is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/09/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | TEM | Buy Now | Tempus AI | $32.35 | 29.83% | → $42 | Initiates | → Overweight | Get Alert |
| 05/30/2024 | A | Buy Now | Agilent Technologies | $125.27 | 23.73% | $165 → $155 | Maintains | Overweight | Get Alert |
| 05/02/2024 | RGEN | Buy Now | Repligen | $120.09 | 66.53% | $230 → $200 | Maintains | Overweight | Get Alert |
| 05/02/2024 | NVST | Buy Now | Envista Holdings | $16.41 | 40.16% | $29 → $23 | Maintains | Overweight | Get Alert |
| 04/25/2024 | TMO | Buy Now | Thermo Fisher Scientific | $531.02 | 22.41% | $600 → $650 | Maintains | Overweight | Get Alert |
| 04/22/2024 | PACB | Buy Now | Pacific Biosciences | $1.30 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 03/06/2024 | AKYA | Buy Now | Akoya Biosciences | $2.05 | 387.8% | $12 → $10 | Maintains | Overweight | Get Alert |
| 03/06/2024 | HSIC | Buy Now | Henry Schein | $64.42 | 36.6% | $82 → $88 | Maintains | Overweight | Get Alert |
| 02/15/2024 | ADPT | Buy Now | Adaptive Biotechnologies | $3.56 | 124.4% | $11 → $8 | Maintains | Overweight | Get Alert |
| 02/14/2024 | BRKR | Buy Now | Bruker | $60.77 | 48.1% | $60 → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 12/20/2023 | RGEN | Buy Now | Repligen | $120.09 | 74.86% | $170 → $210 | Maintains | Overweight | Get Alert |
| 12/20/2023 | A | Buy Now | Agilent Technologies | $125.27 | 31.72% | $140 → $165 | Maintains | Overweight | Get Alert |
| 12/20/2023 | DHR | Buy Now | Danaher | $240.07 | 12.47% | $250 → $270 | Maintains | Overweight | Get Alert |
| 12/12/2023 | HSIC | Buy Now | Henry Schein | $64.42 | 27.29% | $71 → $82 | Upgrade | Neutral → Overweight | Get Alert |
| 11/27/2023 | NSTG | Buy Now | NanoString Technologies | — | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/21/2023 | A | Buy Now | Agilent Technologies | $125.27 | 11.76% | $150 → $140 | Maintains | Overweight | Get Alert |
| 11/08/2023 | WAT | Buy Now | Waters | $282.08 | -11.37% | $260 → $250 | Maintains | Neutral | Get Alert |
| 11/07/2023 | MYGN | Buy Now | Myriad Genetics | $25.29 | -44.63% | $17 → $14 | Maintains | Underweight | Get Alert |
| 11/02/2023 | NVST | Buy Now | Envista Holdings | $16.41 | 95% | $42 → $32 | Maintains | Overweight | Get Alert |
| 10/25/2023 | DHR | Buy Now | Danaher | $240.07 | 4.14% | $260 → $250 | Maintains | Overweight | Get Alert |
| 10/17/2023 | WAT | Buy Now | Waters | $282.08 | -7.83% | $290 → $260 | Maintains | Neutral | Get Alert |
| 10/17/2023 | TMO | Buy Now | Thermo Fisher Scientific | $531.02 | 18.64% | $670 → $630 | Maintains | Overweight | Get Alert |
| 10/17/2023 | RGEN | Buy Now | Repligen | $120.09 | 49.88% | $200 → $180 | Maintains | Overweight | Get Alert |
| 10/17/2023 | MTD | Buy Now | Mettler-Toledo Intl | $1.31K | -16.25% | $1300 → $1100 | Maintains | Neutral | Get Alert |
| 10/17/2023 | BRKR | Buy Now | Bruker | $60.77 | 6.96% | $70 → $65 | Maintains | Neutral | Get Alert |
| 10/17/2023 | RVTY | Buy Now | Revvity | $103.94 | 5.83% | $130 → $110 | Maintains | Neutral | Get Alert |
| 10/17/2023 | DHR | Buy Now | Danaher | $240.07 | 8.3% | $300 → $260 | Maintains | Overweight | Get Alert |
| 08/16/2023 | A | Buy Now | Agilent Technologies | $125.27 | 19.74% | $155 → $150 | Maintains | Overweight | Get Alert |
| 08/07/2023 | MYGN | Buy Now | Myriad Genetics | $25.29 | -32.77% | $18 → $17 | Maintains | Underweight | Get Alert |
| 08/02/2023 | RVTY | Buy Now | Revvity | $103.94 | 25.07% | $120 → $130 | Maintains | Neutral | Get Alert |
| 07/27/2023 | TMO | Buy Now | Thermo Fisher Scientific | $531.02 | 26.17% | $660 → $670 | Maintains | Overweight | Get Alert |
| 05/25/2023 | TMO | Buy Now | Thermo Fisher Scientific | $531.02 | 24.29% | $675 → $660 | Maintains | Overweight | Get Alert |
| 05/24/2023 | A | Buy Now | Agilent Technologies | $125.27 | 23.73% | $170 → $155 | Maintains | Overweight | Get Alert |
| 05/22/2023 | CTLT | Buy Now | Catalent | $57.49 | -21.73% | $90 → $45 | Downgrade | Overweight → Neutral | Get Alert |
| 02/02/2023 | TMO | Buy Now | Thermo Fisher Scientific | $531.02 | 27.11% | $650 → $675 | Maintains | Overweight | Get Alert |
| 11/10/2022 | AMRS | Buy Now | Amyris | — | — | — | Downgrade | Neutral → Underweight | Get Alert |
| 10/27/2022 | TMO | Buy Now | Thermo Fisher Scientific | $531.02 | 22.41% | $715 → $650 | Maintains | Overweight | Get Alert |
| 10/21/2022 | DHR | Buy Now | Danaher | $240.07 | 31.21% | $350 → $315 | Maintains | Overweight | Get Alert |
| 07/29/2022 | TMO | Buy Now | Thermo Fisher Scientific | $531.02 | 34.65% | $700 → $715 | Maintains | Overweight | Get Alert |
| 06/24/2022 | AMRS | Buy Now | Amyris | — | — | — | Initiates | → Neutral | Get Alert |
